Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Gastinne

Showing results (1-10 of 125) with videos related to

Pageof 13
Sort By:
La Revue Du Praticien|November 10, 2009
[Multiple bone myelomas]Murielle Roussel, Thomas Gastinne, Xavier Leleu
Seminars in Hematology|July 26, 2011
Allogeneic stem cell transplantation in mantle cell lymphoma: where are we now and which way should we go?Steven Le Gouill, Mohamad Mohty, Thierry Guillaume, et al.
Transplantation|March 25, 2009
High-dose chemotherapy followed by autologous stem-cell transplantation in liver-transplanted multiple myeloma patients: a report of two casesPierre Peterlin, Thomas Gastinne, Philippe Moreau, et al.
Haematologica|June 4, 2008
FDG-positron-emission tomography for staging and therapeutic assessment in patients with plasmacytomaPierre-Yves Salaun, Thomas Gastinne, Eric Frampas, et al.
Mycoses|January 26, 2016
Epidemiology, risk factor, species distribution, antifungal resistance and outcome of Candidemia at a single French hospital: a 7-year studyLaurent Tadec, Jean-Philippe Talarmin, Thomas Gastinne, et al.
Current Research in Translational Medicine|April 26, 2023
Failure to bispecific-antibody therapy is associated with a short survival in highly pre-treated patients with aggressive B-Cell LymphomasKohar Kevork, Melanie Gouin, Valentin Letailleur, et al.
Hematological Oncology|January 19, 2022
Prognostic value of FDG-PET/CT response for patient selection before chimeric antigen receptor-T-cells therapy in non-Hodgkin lymphomaClément Bailly, Thomas Carlier, Benoit Tessoulin, et al.
Medical Mycology|May 31, 2011
Invasive Myceliophthora thermophila infection mimicking invasive aspergillosis in a neutropenic patient: a new cause of cross-reactivity with the Aspergillus galactomannan serum antigen assayFlorent Morio, François Fraissinet, Thomas Gastinne, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 27, 2010
Long-term follow-up of tandem high-dose therapy with autologous stem cell support for adults with high-risk age-adjusted international prognostic index aggressive non-Hodgkin Lymphomas: a GOELAMS pilot studyHélène Monjanel, Eric Deconinck, Elodie Perrodeau, et al.
British Journal of Haematology|October 14, 2023
Quad-class exposed/refractory myeloma is associated with short survivalBénédicte Piron, Domitille Costes-Tertrais, Thomas Gastinne, et al.
Pageof 13

Showing results (1-10 of 125) with videos related to

Sort By:
Pageof 13
La Revue Du Praticien|November 10, 2009
[Multiple bone myelomas]Murielle Roussel, Thomas Gastinne, Xavier Leleu
Seminars in Hematology|July 26, 2011
Allogeneic stem cell transplantation in mantle cell lymphoma: where are we now and which way should we go?Steven Le Gouill, Mohamad Mohty, Thierry Guillaume, et al.
Transplantation|March 25, 2009
High-dose chemotherapy followed by autologous stem-cell transplantation in liver-transplanted multiple myeloma patients: a report of two casesPierre Peterlin, Thomas Gastinne, Philippe Moreau, et al.
Haematologica|June 4, 2008
FDG-positron-emission tomography for staging and therapeutic assessment in patients with plasmacytomaPierre-Yves Salaun, Thomas Gastinne, Eric Frampas, et al.
Mycoses|January 26, 2016
Epidemiology, risk factor, species distribution, antifungal resistance and outcome of Candidemia at a single French hospital: a 7-year studyLaurent Tadec, Jean-Philippe Talarmin, Thomas Gastinne, et al.
Current Research in Translational Medicine|April 26, 2023
Failure to bispecific-antibody therapy is associated with a short survival in highly pre-treated patients with aggressive B-Cell LymphomasKohar Kevork, Melanie Gouin, Valentin Letailleur, et al.
Hematological Oncology|January 19, 2022
Prognostic value of FDG-PET/CT response for patient selection before chimeric antigen receptor-T-cells therapy in non-Hodgkin lymphomaClément Bailly, Thomas Carlier, Benoit Tessoulin, et al.
Medical Mycology|May 31, 2011
Invasive Myceliophthora thermophila infection mimicking invasive aspergillosis in a neutropenic patient: a new cause of cross-reactivity with the Aspergillus galactomannan serum antigen assayFlorent Morio, François Fraissinet, Thomas Gastinne, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 27, 2010
Long-term follow-up of tandem high-dose therapy with autologous stem cell support for adults with high-risk age-adjusted international prognostic index aggressive non-Hodgkin Lymphomas: a GOELAMS pilot studyHélène Monjanel, Eric Deconinck, Elodie Perrodeau, et al.
British Journal of Haematology|October 14, 2023
Quad-class exposed/refractory myeloma is associated with short survivalBénédicte Piron, Domitille Costes-Tertrais, Thomas Gastinne, et al.
Pageof 13